IMPACT OF CAPSULE TYPE ON THE AERODYNAMIC PERFORMANCES OF A FLUTICASONE PROPIONATE-BASED DRY POWDER UNDER OPTIMAL AND SUBOPTIMAL INHALATION FLOWRATES

被引:0
|
作者
Wauthoz, Nathalie [1 ]
Hennia, Ismael [1 ]
Ecenarro, Susana [2 ]
Amighi, Karim [1 ]
机构
[1] Univ Libre Bruxelles, Lab Pharmaceut & Biopharmaceut, Blvd Triomphe CP207, B-1050 Brussels, Belgium
[2] Qualicaps Europe SAU, Ave Monte Valdelatas 4, Alcobendas 28108, Spain
关键词
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
16
引用
收藏
页码:A6 / A6
页数:1
相关论文
共 12 条
  • [1] Formulation of novel dry powder inhalation for fluticasone propionate and salmeterol xinafoate with capsule-based device
    Kim, Kyeong Soo
    Kim, Jeong Hyun
    Jin, Sung Giu
    Kim, Dong Wuk
    Kim, Jong Oh
    Yong, Chul Soon
    Youn, Yu Seok
    Oh, Kyung Taek
    Woo, Jong Soo
    Choi, Han-Gon
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2018, 23 (02) : 158 - 166
  • [2] Carrier-based dry powder inhalation: Impact of carrier modification on capsule filling processability and in vitro aerodynamic performance
    Faulhammer, Eva
    Wahl, Verena
    Zellnitz, Sarah
    Khinast, Johannes G.
    Paudel, Amrit
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 491 (1-2) : 231 - 242
  • [3] CARRIER-BASED DRY POWDER INHALATION PART I: IMPACT OF CARRIER MODIFICATION ON CAPSULE FILLING PROCESSABILITY AND IN VITRO AERODYNAMIC PERFORMANCE
    Zellnitz, S.
    Faulhammer, E.
    Wahl, V.
    Khinast, J. G.
    Paudel, A.
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2016, 29 (03) : A10 - A10
  • [4] Pharmacokinetics of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler and a multi-dose inhaler
    Mehta, Rashmi
    Daley-Yates, Peter T.
    Jenkins, Kevin
    Bianco, Joseph
    Stylianou, Anastasia
    Louey, Margaret D.
    Chan, Robert H.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2014, 29 (01) : 66 - 73
  • [5] In Vitro Aerodynamic Analysis Of Co-Spray Dried Fluticasone Propionate (fp) And Salmeterol Xinafoate (sx) Dry Powder Inhalation Aerosols With Lactose-Alternative Excipient
    Malapit, M.
    Mallory, E. K.
    Muralidharan, P.
    Phan, H.
    Hayes, D., Jr.
    Mansour, H. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [6] Pharmacokinetics and Pharmacodynamics of Fluticasone Propionate and Salmeterol Delivered as a Combination Dry Powder from a Capsule-Based Inhaler and a Multidose Inhaler in Asthma and COPD Patients
    Daley-Yates, Peter T.
    Mehta, Rashmi
    Chan, Robert H.
    Despa, Simona X.
    Louey, Margaret D.
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2014, 27 (04) : 279 - 289
  • [7] IMPACT OF DIFFERENT CAPSULES FOR DRY POWDER INHALERS ON THE AERODYNAMIC PERFORMANCES OF FORMOTEROL-BASED BINARY AND TERNARY BLENDS
    Wauthoz, Nathalie
    Hennia, Ismael
    Ecenarro, Susana
    Amighi, Karim
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2017, 30 (04) : A6 - A6
  • [8] Assessment of the efficacy and safety of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler and a multi-dose inhaler in patients with asthma
    Chan, Robert
    Sousa, Ana R.
    Mallett, Stephen
    Hynds, Peter
    Homayoun-Valiani, Farshid
    Tabberer, Maggie
    Mehta, Rashmi
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2016, 41 : 19 - 24
  • [9] Comparison of the Pharmacokinetics of Salmeterol and Fluticasone Propionate 50/100 μg Delivered in Combination as a Dry Powder Via a Capsule-Based Inhaler and a Multi-Dose Inhaler
    Mehta, Rashmi
    Riddell, Kylie
    Gupta, Ashutosh
    Louey, Margaret D.
    Chan, Robert H.
    CLINICAL DRUG INVESTIGATION, 2015, 35 (05) : 319 - 326
  • [10] Comparison of the Pharmacokinetics of Salmeterol and Fluticasone Propionate 50/100 µg Delivered in Combination as a Dry Powder Via a Capsule-Based Inhaler and a Multi-Dose Inhaler
    Rashmi Mehta
    Kylie Riddell
    Ashutosh Gupta
    Margaret D Louey
    Robert H. Chan
    Clinical Drug Investigation, 2015, 35 : 319 - 326